Escudier B - Search Results

1

Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.

Perier A, Fregni G, Wittnebel S, Gad S, Allard M, Gervois N, Escudier B, Azzarone B, Caignard A. Perier A, et al. Among authors: escudier b. Oncogene. 2011 Jun 9;30(23):2622-32. doi: 10.1038/onc.2010.638. Epub 2011 Jan 24. Oncogene. 2011. PMID: 21258414

2

Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.

Hercend T, Farace F, Baume D, Charpentier F, Droz JP, Triebel F, Escudier B. Hercend T, et al. Among authors: escudier b. J Biol Response Mod. 1990 Dec;9(6):546-55. J Biol Response Mod. 1990. PMID: 2074441 Clinical Trial.

3

In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.

Gaudin C, Dietrich PY, Robache S, Guillard M, Escudier B, Lacombe MJ, Kumar A, Triebel F, Caignard A. Gaudin C, et al. Among authors: escudier b. Cancer Res. 1995 Feb 1;55(3):685-90. Cancer Res. 1995. PMID: 7834641

4

[Cancer immunotherapy: immunologic bases, reality and hopes].

Dietrich PY, Farace F, Caignard A, Escudier B, Triebel F. Dietrich PY, et al. Among authors: escudier b. Bull Cancer. 1993 Jul;80(7):584-600. Bull Cancer. 1993. PMID: 8204939 Review. French.

5

Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma.

Farace F, Angevin E, Escudier B, Caignard A, Dietrich PY, Genevee C, Hercend T, Triebel F. Farace F, et al. Among authors: escudier b. Int J Cancer. 1993 Jul 9;54(5):741-7. doi: 10.1002/ijc.2910540506. Int J Cancer. 1993. PMID: 8325704

6

Analysis of T-cell-receptor variable gene segment usage in peripheral-blood lymphocytes of advanced cancer patients.

Angevin E, Farace F, Genevée C, Henry-Amar M, Caignard A, Dietrich PY, Escudier B, Hercend T, Triebel F. Angevin E, et al. Among authors: escudier b. Int J Cancer. 1993 Apr 22;54(1):60-7. doi: 10.1002/ijc.2910540111. Int J Cancer. 1993. PMID: 8478148

7

In situ demonstration of renal-cell-carcinoma-specific T-cell clones.

Caignard A, Guillard M, Gaudin C, Escudier B, Triebel F, Dietrich PY. Caignard A, et al. Among authors: escudier b. Int J Cancer. 1996 May 16;66(4):564-70. doi: 10.1002/(SICI)1097-0215(19960516)66:4<564::AID-IJC23>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8635875

8

Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas.

Guerra N, Guillard M, Angevin E, Echchakir H, Escudier B, Moretta A, Chouaib S, Caignard A. Guerra N, et al. Among authors: escudier b. Blood. 2000 May 1;95(9):2883-9. Blood. 2000. PMID: 10779435 Free article.

9

The sensitivity of renal cell carcinoma cells to interferon alpha correlates with p53-induction and involves Bax.

Wittnebel S, Jalil A, Thiery J, DaRocha S, Viey E, Escudier B, Chouaib S, Caignard A. Wittnebel S, et al. Among authors: escudier b. Eur Cytokine Netw. 2005 Jun;16(2):123-7. Eur Cytokine Netw. 2005. PMID: 15941683 Free article.

10

[Metastatic renal cell carcinoma and its treatments].

Escudier B. Escudier B. Ann Urol (Paris). 2006 Nov;40 Suppl 3:S82-5. doi: 10.1016/s0003-4401(06)80029-x. Ann Urol (Paris). 2006. PMID: 17366861 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters